Compare Entergy Corporation (ETR) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Entergy Corporation vs Moderna, Inc. — how do they compare? Entergy Corporation trades at $102.8 (market cap $49.52B), while Moderna, Inc. trades at $142.73 (market cap $58.56B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Entergy Corporation pays a 2.47% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| ETR | MRNA | |
|---|---|---|
Market Cap | $49.52B | $58.56B |
Sector | Utilities | Health |
52-Week High | $117.91 | $174.38 |
52-Week Low | $87.83 | $22.36 |
Enterprise Value | $80.29B | $54.71B |
Dividend Yield | 2.47% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Moderna (MRNA) trades at $143.97, up 5.38% with strong bullish momentum from recent cancer vaccine developments. The stock shows positive technical signals with moving averages indicating bullish trends and support at $136. Fundamentally, while revenue has declined from pandemic peaks to $1.92B in 2025, the company continues to beat earnings expectations and shows improving cash flow trends with net positive cash flow of $668M in 2025.
Moderna presents a high-risk, high-reward opportunity with promising pipeline developments offset by significant financial losses. The cancer vaccine breakthrough provides substantial upside potential, but investors face challenges from persistent negative margins, competitive threats, and Wall Street's cautious stance with a consensus price target of $90.08 well below current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Entergy Corporation
Entergy is an energy company that operates regulated electric utilities and power generation businesses in the United States. Its generation portfolio includes nuclear, natural gas, and renewable resources.
Read more on ETR →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
